Related Experiment Video
Updated: Jan 23, 2026

13:50
A Microfluidic Device with Groove Patterns for Studying Cellular Behavior
Published on: August 30, 2007
12.9K
Under Azar and Boehler, CMMI Gets Its Groove Back
Summary
The Center for Medicare and Medicaid Innovation (CMMI) is revitalizing its efforts to test new healthcare payment and care models. Under new leadership, CMMI is increasing its output of innovative initiatives.
Area of Science:
- Healthcare policy
- Health economics
- Public health administration
Background:
- The Center for Medicare and Medicaid Innovation (CMMI) was established by the Affordable Care Act (ACA) to test innovative payment and delivery models.
- CMMI has the authority to experiment with new healthcare payment and care models.
- Recent leadership changes at HHS and CMMI may indicate a renewed focus on CMMI's mission.
Purpose of the Study:
- To assess the recent activity and direction of the Center for Medicare and Medicaid Innovation (CMMI) under new leadership.
- To identify any shifts in the pace or nature of new model development and implementation by CMMI.
Main Methods:
- Qualitative analysis of recent announcements and initiatives from CMMI.
- Review of leadership appointments and stated priorities within the Department of Health and Human Services (HHS) concerning CMMI.
- Monitoring of the volume and type of new payment and care models being introduced.
Main Results:
- The Center for Medicare and Medicaid Innovation (CMMI) has shown increased activity in developing and launching new healthcare payment and care models.
- New leadership, appointed in April, appears to be driving a surge in CMMI's output.
- There is a notable increase in the number of experimental models being introduced by CMMI.
Conclusions:
- The Center for Medicare and Medicaid Innovation (CMMI) is demonstrating renewed vigor in its mission to innovate healthcare payment and delivery.
- The current administration's focus, particularly under HHS Secretary Alex Azar and CMMI Director Adam Boehler, is leading to a significant increase in CMMI's experimental model development.
More Related Videos
Related Concept Videos
Cis-regulatory Sequences
11.6K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.6K
Eukaryotic Transcription Activators
12.6K
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.6K

